Shin Poong Pharm Co., Ltd.
http://www.shinpoong.co.kr/en/main/main.php
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Shin Poong Pharm Co., Ltd.
Korean COVID-19 Contenders Still Racing Toward Finish Line
Hyundai Bioscience’s niclosamide-based oral antiviral moves into Phase II, joining other Korean COVID-19 treatment candidates in the pivotal trial stages, while SK Bioscience’s Phase III recombinant protein vaccine gears up for global market entry.
‘Regulatory Reliance’ Projects Bearing Fruit In Caribbean & Africa
Initiatives to promote information sharing and reliance among developing country regulators are bearing fruit in the Caribbean and Africa, although much works remains to be done, according to speakers at last week’s pre-ICDRA conference in Dublin.
Korea steps up efforts to contain MERS outbreak
The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea is worsening, with the number of confirmed cases and fatalities continuing to climb. Struggling to contain the spread of the disease, the central government has announced it will step up efforts with provincial authorities, the private sector, the military and schools to ease the situation.
Korea Steps Up Efforts To Contain MERS Outbreak
The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea is worsening, with the number of confirmed cases and fatalities continuing to climb. Struggling to contain the spread of the disease, the central government has announced it will step up efforts with provincial authorities, the private sector, the military and schools to ease the situation.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Laser
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice